What is Adalimumab-afzb: Uses, Dosage, Side Effects and More

Adalimumab-afzb is a biosimilar medication that helps treat autoimmune conditions by targeting specific proteins that cause inflammation in your body. It's essentially a laboratory-made version of a natural protein that your immune system normally produces to fight disease.

This medication belongs to a class called TNF blockers, which work by blocking tumor necrosis factor-alpha, a protein that contributes to inflammation and joint damage. You might know it by its brand name Abrilada, and it's designed to work similarly to the original adalimumab medication Humira.

What is Adalimumab-afzb Used For?

Adalimumab-afzb treats several autoimmune conditions where your immune system mistakenly attacks healthy parts of your body. Your doctor might prescribe it when your condition hasn't responded well to other treatments or when you need stronger medication to control your symptoms.

The most common conditions it treats include rheumatoid arthritis, where it helps reduce joint pain and swelling that can make daily activities difficult. It's also effective for psoriatic arthritis, which causes both skin patches and joint inflammation.

For inflammatory bowel conditions, this medication can help manage Crohn's disease and ulcerative colitis by reducing intestinal inflammation. It's particularly helpful when these conditions cause persistent symptoms that interfere with your quality of life.

Other conditions it treats include ankylosing spondylitis (a type of arthritis affecting the spine), plaque psoriasis (thick, scaly skin patches), and hidradenitis suppurativa (painful skin lumps). In some cases, doctors also prescribe it for certain types of eye inflammation called uveitis.

How Does Adalimumab-afzb Work?

Adalimumab-afzb works by blocking TNF-alpha, a protein that acts like a messenger telling your immune system to create inflammation. When you have an autoimmune condition, your body produces too much of this protein, leading to ongoing inflammation and tissue damage.

Think of TNF-alpha as an overly enthusiastic security guard that keeps sounding false alarms. This medication essentially tells that security guard to calm down and stop triggering unnecessary inflammatory responses in your body.

This is considered a strong medication because it significantly suppresses your immune system's activity. While this helps control your autoimmune condition, it also means your body may have a harder time fighting off infections while you're taking it.

The medication typically takes several weeks to months to show its full effects. You might notice some improvement in symptoms within the first few weeks, but the maximum benefit usually develops over 3 to 6 months of consistent treatment.

How Should I Take Adalimumab-afzb?

Adalimumab-afzb is given as a subcutaneous injection, which means you inject it under the skin using a pre-filled pen or syringe. Your healthcare provider will teach you how to inject it yourself, though some people prefer to have a family member or caregiver help with the injections.

The typical dosing schedule is every other week, though some conditions may require different timing. Your doctor will determine the exact dose and frequency based on your specific condition and how well you respond to treatment.

You can inject the medication into your thigh, stomach area (avoiding the area around your belly button), or the outer area of your upper arm. It's important to rotate injection sites to prevent skin irritation and ensure proper absorption.

Before injecting, let the medication warm to room temperature for about 15 to 30 minutes. This helps reduce injection site discomfort. Never shake the medication or heat it in ways other than letting it sit at room temperature.

You can take this medication with or without food, since it's injected rather than taken by mouth. However, maintaining a consistent schedule helps ensure steady levels of the medication in your system.

How Long Should I Take Adalimumab-afzb For?

The duration of treatment with adalimumab-afzb varies significantly depending on your specific condition and how well you respond to the medication. Many people with chronic autoimmune conditions take it for years to maintain symptom control.

Your doctor will regularly monitor your response to treatment and may adjust the duration based on how well your condition is controlled. Some people may be able to reduce the frequency of injections or take breaks from treatment if their condition goes into remission.

For conditions like rheumatoid arthritis or inflammatory bowel disease, long-term treatment is often necessary because these are chronic conditions that tend to flare up when treatment is stopped. However, your doctor will work with you to find the minimal effective dose and duration.

Regular follow-up appointments are essential to assess whether continued treatment is necessary and beneficial. Your healthcare provider will weigh the benefits of ongoing treatment against potential risks and side effects.

What Are the Side Effects of Adalimumab-afzb?

Like all medications that affect your immune system, adalimumab-afzb can cause side effects, though not everyone experiences them. Understanding what to watch for helps you work with your healthcare provider to manage any issues that arise.

The most common side effects are generally mild and manageable with proper care and monitoring.

• Injection site reactions like redness, swelling, or mild pain
• Upper respiratory infections such as colds or sinus infections
• Headaches that may occur especially when starting treatment
• Mild nausea or stomach discomfort
• Fatigue or feeling more tired than usual

These common side effects often improve as your body adjusts to the medication over the first few weeks of treatment.

More serious side effects can occur but are less common. These require immediate medical attention and include signs of serious infections, unusual bruising or bleeding, and persistent fever or flu-like symptoms.

• Serious infections including tuberculosis, fungal infections, or bacterial infections
• Liver problems with symptoms like yellowing of skin or eyes, dark urine, or severe fatigue
• Blood disorders causing unusual bruising, bleeding, or persistent fever
• Allergic reactions with symptoms like difficulty breathing, swelling, or severe rash
• Nervous system problems including numbness, tingling, or vision changes

Contact your healthcare provider immediately if you experience any of these serious side effects.

There are also some rare but significant risks associated with long-term use. These include an increased risk of certain types of cancer, particularly lymphoma, though this risk remains relatively low. Your doctor will discuss these risks with you and monitor you regularly.

Some people may experience reactivation of hepatitis B if they're carriers of the virus, which is why your doctor will test for this before starting treatment. Heart failure can also worsen in people who already have this condition.

Who Should Not Take Adalimumab-afzb?

Certain people should not take adalimumab-afzb due to increased risks of serious complications. Your doctor will carefully review your medical history to determine if this medication is safe for you.

People with active infections should not start this medication because it suppresses the immune system and could make infections worse. This includes both serious infections like tuberculosis and common infections like the flu or pneumonia.

If you have a history of hepatitis B, this medication could cause the virus to become active again, potentially leading to serious liver problems. Your doctor will test for hepatitis B before prescribing adalimumab-afzb.

People with moderate to severe heart failure should generally avoid this medication because it can worsen heart function. If you have any heart problems, your doctor will carefully evaluate whether the benefits outweigh the risks.

Certain cancers, particularly blood cancers like lymphoma, are a concern with this medication. If you have a current cancer or recent history of cancer, your doctor will need to weigh the risks and benefits very carefully.

People with multiple sclerosis or other demyelinating diseases should avoid this medication because it may worsen these neurological conditions. Live vaccines should also be avoided while taking adalimumab-afzb.

Pregnancy and breastfeeding require special consideration. While the medication may be used during pregnancy if absolutely necessary, it's important to discuss the risks and benefits with your doctor before conception if possible.

Adalimumab-afzb Brand Names

Adalimumab-afzb is marketed under the brand name Abrilada in the United States. This biosimilar medication is manufactured by Pfizer and was approved by the FDA as a more affordable alternative to the original adalimumab medication.

As a biosimilar, Abrilada is designed to work in the same way as Humira, the original adalimumab medication. The FDA requires biosimilars to demonstrate that they're highly similar to the original medication in terms of safety and effectiveness.

You might see different brand names for adalimumab biosimilars in other countries, but Abrilada is the primary brand name used in the United States. Your pharmacy may also refer to it by its generic name, adalimumab-afzb.

Adalimumab-afzb Alternatives

Several alternatives exist if adalimumab-afzb isn't suitable for you or doesn't provide adequate symptom control. Your doctor can help you explore these options based on your specific condition and medical history.

Other TNF blockers work similarly to adalimumab-afzb but may have different dosing schedules or side effect profiles. These include etanercept (Enbrel), infliximab (Remicade), and certolizumab pegol (Cimzia).

For some conditions, non-TNF biologics might be more appropriate. These include medications like rituximab (Rituxan), abatacept (Orencia), or tocilizumab (Actemra), which target different parts of the immune system.

Newer medications called JAK inhibitors, such as tofacitinib (Xeljanz) or baricitinib (Olumiant), offer oral alternatives to injectable biologics for certain conditions. These work by blocking different inflammatory pathways.

Traditional disease-modifying antirheumatic drugs (DMARDs) like methotrexate, sulfasalazine, or hydroxychloroquine may also be options, either alone or in combination with other treatments.

Is Adalimumab-afzb Better Than Humira?

Adalimumab-afzb (Abrilada) and Humira contain the same active ingredient and work in essentially the same way in your body. The main difference is that Abrilada is a biosimilar, which means it's a highly similar version of the original Humira medication.

In terms of effectiveness, clinical studies have shown that biosimilars like adalimumab-afzb work just as well as the original medication. The FDA requires biosimilars to demonstrate that they're highly similar in terms of safety, purity, and potency.

The primary advantage of adalimumab-afzb is often cost. Biosimilars are typically less expensive than the original brand-name medication, which can make treatment more affordable for many people.

Some people may notice slight differences in injection experience or minor side effects when switching between the original medication and biosimilar, but these differences are usually minimal. Your doctor can help you determine which option is best for your specific situation.

If you're currently taking Humira and it's working well for you, there may be no need to switch. However, if cost is a concern or your insurance prefers the biosimilar, switching to adalimumab-afzb is generally considered safe and effective.